FDA Alerts Archive for 2024

January 5, 2024

• Leiters Health Issues Voluntary Nationwide Recall of Vancomycin IV Bags, Phenylephrine IV Bags, and Fentanyl IV Bags Due to Potential for Superpotent Drug

January 11, 2024

• Drug Safety Communication: Certain Type of Medicines Approved for Type 2 Diabetes and Obesity - Update on FDA’s Ongoing Evaluation of Reports of Suicidal Thoughts or Actions

January 19, 2024

• Kilitch Healthcare India Limited Issues Amendments in Last Voluntary Nationwide Recall Press Release
• Drug Safety Communication: Prolia (denosumab) - FDA Adds Boxed Warning for Increased Risk of Severe Hypocalcemia in Patients with Advanced Chronic Kidney Disease

January 23, 2024

• Update: FDA Warns Consumers Not to Purchase or Use Neptune’s Fix or Any Tianeptine Product Due to Serious Risks

January 24, 2024

• Haleon Issues Voluntary Nationwide Recall of Robitussin Honey CF Max Day Adult and Robitussin Honey CF Max Nighttime Adult Products Due to Microbial Contamination
• Azurity Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Zenzedi (dextroamphetamine sulfate tablets, USP) 30 mg Due to a Mislabeled Package During Manufacturing

January 28, 2024

• Neptune Resources, LLC Issues Voluntary Nationwide Recall of Neptune’s Fix

January 31, 2024

• FDA Warns Consumers of Contaminated Copycat Eye Drops

February 1, 2024

• Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid Due to the Presence of Benzene

February 2, 2024

• Today The World Issues Voluntary Nationwide Recall of All Lots of Arize Herbal Dietary Supplement Capsules Due to the Presence of Undeclared Nortadalafil
• Today The World Issues Voluntary Nationwide Recall of All Lots of Sustain and Schwinnng brand Dietary Supplement Capsules Due to the Presence of Undeclared Tadalafil and Nortadalafil

February 6, 2024

• FDA Safety Communication: Recall of Certain Saline and Sterile Water Medical Products Associated with Nurse Assist

February 17, 2024

• Nordic Naturals Issues Voluntary Recall of Baby's Vitamin D3 Liquid Due to Elevated Levels of Vitamin D3

February 22, 2024

• Brassica Pharma Pvt. Ltd. Issues Voluntary Nationwide Recall of Eye Ointment Products Due to Potential Lack of Sterility

March 12, 2024

• Par Pharmaceutical Issues Voluntary Nationwide Recall of One Lot of Treprostinil Injection Due to Potential for Silicone Particulates

March 19, 2024

• Pyramid Wholesale Issues Recall of Various Brands of Products Sold as Dietary Supplements for Sexual Enhancement

March 26, 2024

• FDA Warns Consumers to Avoid Certain Topical Pain Relief Products Due to Potential for Dangerous Health Effects

March 27, 2024

• Amneal Issues a Nationwide Voluntary Recall of Vancomycin Hydrochloride for Oral Solution USP, 250mg/5mL Due to the Potential for Some Bottles to be Super Potent

March 28, 2024

• Eugia US LLC Issues Voluntary Nationwide Recall of Methocarbamol Injection, USP 1000 mg/10 mL Due to Presence of White Particles

March 29, 2024

• AvKARE, LLC. Issues Voluntary Nationwide Recall of Atovaquone Oral Suspension, USP 750 mg/5 mL Due to Potential Bacillus Cereus Contamination

April 2, 2024

• ForeverMen Supplements Recalled

April 5, 2024

• Aruba Aloe Balm N.V. Issues Voluntary Nationwide Recall of Aruba Aloe Hand Sanitizer Gel Alcohol 80% and Aruba Aloe Alcoholada Gel Due to Presence of Methanol

April 9, 2024

• Otsuka Initiates Voluntary Nationwide Recall of Certain Lots of Abilify (aripiprazole) Tablets Due to Drug Product Cross-Contamination on Manufacturing Equipment

April 16, 2024

• Counterfeit Versions of Botox Found in Multiple States

April 18, 2024

• FDA Requires Boxed Warning for T Cell Malignancies Following Treatment with BCMA-Directed or CD19-Directed Autologous CAR T Cell Immunotherapies

April 22, 2024

• Stop Clopez Corp. Issues Voluntary Worldwide Recall of Schwinnng Capsules Due to the Presence of Undeclared Nortadalafil

April 23, 2024

• Dr. Reddy’s Issues Voluntary Nationwide Recall of Sapropterin Dihydrochloride Powder for Oral Solution 100 mg Due to Sub-Potency

April 29, 2024

• FDA Alerts Health Care Professionals of Pregnancy Problems Associated with Thiopurines

May 13, 2024

• FDA Safety Communication: Do Not Use Cue Health’s COVID-19 Tests Due to Risk of False Results